nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—NR0B1—Dexamethasone—psoriasis	0.404	1	CbGbCtD
Vorinostat—HDAC1—manus—psoriasis	0.0195	0.235	CbGeAlD
Vorinostat—HDAC1—manual digit—psoriasis	0.0191	0.23	CbGeAlD
Vorinostat—NCOR1—skin of body—psoriasis	0.00632	0.076	CbGeAlD
Vorinostat—HDAC8—tendon—psoriasis	0.00569	0.0684	CbGeAlD
Vorinostat—HDAC3—skin of body—psoriasis	0.00554	0.0666	CbGeAlD
Vorinostat—HDAC4—tendon—psoriasis	0.00553	0.0665	CbGeAlD
Vorinostat—HDAC2—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.00536	0.953	CbGdCrCtD
Vorinostat—HDAC1—skin of body—psoriasis	0.00508	0.061	CbGeAlD
Vorinostat—HDAC3—tendon—psoriasis	0.00422	0.0507	CbGeAlD
Vorinostat—HDAC1—tendon—psoriasis	0.00386	0.0465	CbGeAlD
Vorinostat—HDAC9—tendon—psoriasis	0.0038	0.0457	CbGeAlD
Vorinostat—HDAC2—skin of body—psoriasis	0.00255	0.0307	CbGeAlD
Vorinostat—HDAC2—tendon—psoriasis	0.00194	0.0234	CbGeAlD
Vorinostat—Hypokalaemia—Betamethasone—psoriasis	0.000432	0.00179	CcSEcCtD
Vorinostat—Anaemia—Mycophenolic acid—psoriasis	0.00043	0.00179	CcSEcCtD
Vorinostat—Myocardial infarction—Prednisolone—psoriasis	0.00043	0.00178	CcSEcCtD
Vorinostat—Acute coronary syndrome—Hydrocortisone—psoriasis	0.000422	0.00175	CcSEcCtD
Vorinostat—Lethargy—Prednisone—psoriasis	0.000422	0.00175	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Triamcinolone—psoriasis	0.00042	0.00174	CcSEcCtD
Vorinostat—Myocardial infarction—Hydrocortisone—psoriasis	0.00042	0.00174	CcSEcCtD
Vorinostat—Syncope—Mycophenolic acid—psoriasis	0.000417	0.00173	CcSEcCtD
Vorinostat—Leukopenia—Mycophenolic acid—psoriasis	0.000416	0.00173	CcSEcCtD
Vorinostat—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000416	0.00173	CcSEcCtD
Vorinostat—Asthenia—Acitretin—psoriasis	0.000414	0.00172	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.000413	0.00172	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—psoriasis	0.000413	0.00171	CcSEcCtD
Vorinostat—Vomiting—Calcitriol—psoriasis	0.000413	0.00171	CcSEcCtD
Vorinostat—Loss of consciousness—Mycophenolic acid—psoriasis	0.000409	0.0017	CcSEcCtD
Vorinostat—Pruritus—Acitretin—psoriasis	0.000409	0.0017	CcSEcCtD
Vorinostat—Pruritus—Fluocinolone Acetonide—psoriasis	0.000407	0.00169	CcSEcCtD
Vorinostat—Headache—Calcitriol—psoriasis	0.000407	0.00169	CcSEcCtD
Vorinostat—Cough—Mycophenolic acid—psoriasis	0.000406	0.00169	CcSEcCtD
Vorinostat—Acute coronary syndrome—Triamcinolone—psoriasis	0.000397	0.00165	CcSEcCtD
Vorinostat—Chest pain—Mycophenolic acid—psoriasis	0.000396	0.00164	CcSEcCtD
Vorinostat—Diarrhoea—Acitretin—psoriasis	0.000395	0.00164	CcSEcCtD
Vorinostat—Myocardial infarction—Triamcinolone—psoriasis	0.000395	0.00164	CcSEcCtD
Vorinostat—Decreased appetite—Hydroxyurea—psoriasis	0.000394	0.00164	CcSEcCtD
Vorinostat—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000394	0.00164	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000391	0.00163	CcSEcCtD
Vorinostat—Fatigue—Hydroxyurea—psoriasis	0.000391	0.00162	CcSEcCtD
Vorinostat—Chills—Cyclosporine—psoriasis	0.000388	0.00161	CcSEcCtD
Vorinostat—Constipation—Hydroxyurea—psoriasis	0.000388	0.00161	CcSEcCtD
Vorinostat—Dry mouth—Mycophenolic acid—psoriasis	0.000387	0.00161	CcSEcCtD
Vorinostat—Nausea—Calcitriol—psoriasis	0.000386	0.0016	CcSEcCtD
Vorinostat—Alopecia—Cyclosporine—psoriasis	0.000382	0.00159	CcSEcCtD
Vorinostat—Dizziness—Acitretin—psoriasis	0.000382	0.00159	CcSEcCtD
Vorinostat—Dizziness—Fluocinolone Acetonide—psoriasis	0.000381	0.00158	CcSEcCtD
Vorinostat—Chills—Mycophenolate mofetil—psoriasis	0.000378	0.00157	CcSEcCtD
Vorinostat—Infection—Mycophenolic acid—psoriasis	0.000377	0.00157	CcSEcCtD
Vorinostat—Hypokalaemia—Prednisone—psoriasis	0.000376	0.00156	CcSEcCtD
Vorinostat—Shock—Mycophenolic acid—psoriasis	0.000374	0.00155	CcSEcCtD
Vorinostat—Alopecia—Mycophenolate mofetil—psoriasis	0.000373	0.00155	CcSEcCtD
Vorinostat—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000372	0.00154	CcSEcCtD
Vorinostat—Weight decreased—Betamethasone—psoriasis	0.000371	0.00154	CcSEcCtD
Vorinostat—Weight decreased—Dexamethasone—psoriasis	0.000371	0.00154	CcSEcCtD
Vorinostat—Hyperglycaemia—Dexamethasone—psoriasis	0.00037	0.00154	CcSEcCtD
Vorinostat—Hyperglycaemia—Betamethasone—psoriasis	0.00037	0.00154	CcSEcCtD
Vorinostat—Dysgeusia—Cyclosporine—psoriasis	0.000369	0.00153	CcSEcCtD
Vorinostat—Vomiting—Acitretin—psoriasis	0.000367	0.00152	CcSEcCtD
Vorinostat—Vomiting—Fluocinolone Acetonide—psoriasis	0.000366	0.00152	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Methotrexate—psoriasis	0.000366	0.00152	CcSEcCtD
Vorinostat—Anorexia—Mycophenolic acid—psoriasis	0.000362	0.0015	CcSEcCtD
Vorinostat—Muscle spasms—Cyclosporine—psoriasis	0.000362	0.0015	CcSEcCtD
Vorinostat—Headache—Acitretin—psoriasis	0.000362	0.0015	CcSEcCtD
Vorinostat—Headache—Fluocinolone Acetonide—psoriasis	0.000361	0.0015	CcSEcCtD
Vorinostat—Acute coronary syndrome—Betamethasone—psoriasis	0.000361	0.0015	CcSEcCtD
Vorinostat—Acute coronary syndrome—Dexamethasone—psoriasis	0.000361	0.0015	CcSEcCtD
Vorinostat—Dysgeusia—Mycophenolate mofetil—psoriasis	0.00036	0.00149	CcSEcCtD
Vorinostat—Myocardial infarction—Betamethasone—psoriasis	0.000358	0.00149	CcSEcCtD
Vorinostat—Myocardial infarction—Dexamethasone—psoriasis	0.000358	0.00149	CcSEcCtD
Vorinostat—Body temperature increased—Hydroxyurea—psoriasis	0.000358	0.00149	CcSEcCtD
Vorinostat—Muscle spasms—Mycophenolate mofetil—psoriasis	0.000353	0.00147	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—psoriasis	0.000352	0.00146	CcSEcCtD
Vorinostat—Anaemia—Cyclosporine—psoriasis	0.000348	0.00144	CcSEcCtD
Vorinostat—Angioedema—Cyclosporine—psoriasis	0.000344	0.00143	CcSEcCtD
Vorinostat—Nausea—Acitretin—psoriasis	0.000343	0.00142	CcSEcCtD
Vorinostat—Nausea—Fluocinolone Acetonide—psoriasis	0.000342	0.00142	CcSEcCtD
Vorinostat—Anaemia—Mycophenolate mofetil—psoriasis	0.000339	0.00141	CcSEcCtD
Vorinostat—Leukopenia—Cyclosporine—psoriasis	0.000337	0.0014	CcSEcCtD
Vorinostat—Angioedema—Mycophenolate mofetil—psoriasis	0.000335	0.00139	CcSEcCtD
Vorinostat—Neutropenia—Prednisone—psoriasis	0.000334	0.00139	CcSEcCtD
Vorinostat—Decreased appetite—Mycophenolic acid—psoriasis	0.00033	0.00137	CcSEcCtD
Vorinostat—Syncope—Mycophenolate mofetil—psoriasis	0.000329	0.00137	CcSEcCtD
Vorinostat—Leukopenia—Mycophenolate mofetil—psoriasis	0.000329	0.00136	CcSEcCtD
Vorinostat—Cough—Cyclosporine—psoriasis	0.000328	0.00136	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000328	0.00136	CcSEcCtD
Vorinostat—Fatigue—Mycophenolic acid—psoriasis	0.000327	0.00136	CcSEcCtD
Vorinostat—Asthenia—Hydroxyurea—psoriasis	0.000325	0.00135	CcSEcCtD
Vorinostat—Constipation—Mycophenolic acid—psoriasis	0.000325	0.00135	CcSEcCtD
Vorinostat—Weight decreased—Prednisone—psoriasis	0.000323	0.00134	CcSEcCtD
Vorinostat—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000323	0.00134	CcSEcCtD
Vorinostat—Hyperglycaemia—Prednisone—psoriasis	0.000322	0.00134	CcSEcCtD
Vorinostat—Chest pain—Cyclosporine—psoriasis	0.00032	0.00133	CcSEcCtD
Vorinostat—Cough—Mycophenolate mofetil—psoriasis	0.00032	0.00133	CcSEcCtD
Vorinostat—Acute coronary syndrome—Prednisone—psoriasis	0.000314	0.0013	CcSEcCtD
Vorinostat—Dry mouth—Cyclosporine—psoriasis	0.000313	0.0013	CcSEcCtD
Vorinostat—Angioedema—Prednisolone—psoriasis	0.000313	0.0013	CcSEcCtD
Vorinostat—Chest pain—Mycophenolate mofetil—psoriasis	0.000313	0.0013	CcSEcCtD
Vorinostat—Myocardial infarction—Prednisone—psoriasis	0.000312	0.0013	CcSEcCtD
Vorinostat—Diarrhoea—Hydroxyurea—psoriasis	0.00031	0.00129	CcSEcCtD
Vorinostat—Dysgeusia—Triamcinolone—psoriasis	0.000308	0.00128	CcSEcCtD
Vorinostat—Syncope—Prednisolone—psoriasis	0.000307	0.00128	CcSEcCtD
Vorinostat—Dry mouth—Mycophenolate mofetil—psoriasis	0.000306	0.00127	CcSEcCtD
Vorinostat—Angioedema—Hydrocortisone—psoriasis	0.000306	0.00127	CcSEcCtD
Vorinostat—Infection—Cyclosporine—psoriasis	0.000305	0.00127	CcSEcCtD
Vorinostat—Loss of consciousness—Prednisolone—psoriasis	0.000301	0.00125	CcSEcCtD
Vorinostat—Thrombocytopenia—Cyclosporine—psoriasis	0.000301	0.00125	CcSEcCtD
Vorinostat—Body temperature increased—Mycophenolic acid—psoriasis	0.0003	0.00125	CcSEcCtD
Vorinostat—Syncope—Hydrocortisone—psoriasis	0.0003	0.00125	CcSEcCtD
Vorinostat—Dizziness—Hydroxyurea—psoriasis	0.0003	0.00124	CcSEcCtD
Vorinostat—Infection—Mycophenolate mofetil—psoriasis	0.000298	0.00124	CcSEcCtD
Vorinostat—Shock—Mycophenolate mofetil—psoriasis	0.000295	0.00122	CcSEcCtD
Vorinostat—Loss of consciousness—Hydrocortisone—psoriasis	0.000294	0.00122	CcSEcCtD
Vorinostat—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000293	0.00122	CcSEcCtD
Vorinostat—Anorexia—Cyclosporine—psoriasis	0.000293	0.00122	CcSEcCtD
Vorinostat—Alopecia—Dexamethasone—psoriasis	0.00029	0.0012	CcSEcCtD
Vorinostat—Alopecia—Betamethasone—psoriasis	0.00029	0.0012	CcSEcCtD
Vorinostat—Vomiting—Hydroxyurea—psoriasis	0.000288	0.0012	CcSEcCtD
Vorinostat—Angioedema—Triamcinolone—psoriasis	0.000288	0.0012	CcSEcCtD
Vorinostat—Anorexia—Mycophenolate mofetil—psoriasis	0.000286	0.00119	CcSEcCtD
Vorinostat—Headache—Hydroxyurea—psoriasis	0.000284	0.00118	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—psoriasis	0.000283	0.00118	CcSEcCtD
Vorinostat—Syncope—Triamcinolone—psoriasis	0.000282	0.00117	CcSEcCtD
Vorinostat—Neutropenia—Methotrexate—psoriasis	0.000279	0.00116	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—psoriasis	0.000277	0.00115	CcSEcCtD
Vorinostat—Loss of consciousness—Triamcinolone—psoriasis	0.000277	0.00115	CcSEcCtD
Vorinostat—Shock—Prednisolone—psoriasis	0.000275	0.00114	CcSEcCtD
Vorinostat—Cough—Triamcinolone—psoriasis	0.000275	0.00114	CcSEcCtD
Vorinostat—Asthenia—Mycophenolic acid—psoriasis	0.000272	0.00113	CcSEcCtD
Vorinostat—Infection—Hydrocortisone—psoriasis	0.000271	0.00113	CcSEcCtD
Vorinostat—Nausea—Hydroxyurea—psoriasis	0.000269	0.00112	CcSEcCtD
Vorinostat—Pruritus—Mycophenolic acid—psoriasis	0.000269	0.00112	CcSEcCtD
Vorinostat—Shock—Hydrocortisone—psoriasis	0.000269	0.00112	CcSEcCtD
Vorinostat—Decreased appetite—Cyclosporine—psoriasis	0.000267	0.00111	CcSEcCtD
Vorinostat—HDAC2—Levonorgestrel—Hydrocortisone—psoriasis	0.000265	0.0472	CbGdCrCtD
Vorinostat—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000265	0.0011	CcSEcCtD
Vorinostat—Fatigue—Cyclosporine—psoriasis	0.000265	0.0011	CcSEcCtD
Vorinostat—Constipation—Cyclosporine—psoriasis	0.000263	0.00109	CcSEcCtD
Vorinostat—Dry mouth—Triamcinolone—psoriasis	0.000262	0.00109	CcSEcCtD
Vorinostat—Angioedema—Betamethasone—psoriasis	0.000261	0.00108	CcSEcCtD
Vorinostat—Angioedema—Dexamethasone—psoriasis	0.000261	0.00108	CcSEcCtD
Vorinostat—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00026	0.00108	CcSEcCtD
Vorinostat—Anorexia—Hydrocortisone—psoriasis	0.00026	0.00108	CcSEcCtD
Vorinostat—Diarrhoea—Mycophenolic acid—psoriasis	0.00026	0.00108	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000259	0.00107	CcSEcCtD
Vorinostat—Syncope—Dexamethasone—psoriasis	0.000256	0.00106	CcSEcCtD
Vorinostat—Syncope—Betamethasone—psoriasis	0.000256	0.00106	CcSEcCtD
Vorinostat—Constipation—Mycophenolate mofetil—psoriasis	0.000256	0.00106	CcSEcCtD
Vorinostat—Infection—Triamcinolone—psoriasis	0.000255	0.00106	CcSEcCtD
Vorinostat—Shock—Triamcinolone—psoriasis	0.000253	0.00105	CcSEcCtD
Vorinostat—Alopecia—Prednisone—psoriasis	0.000253	0.00105	CcSEcCtD
Vorinostat—Loss of consciousness—Dexamethasone—psoriasis	0.000251	0.00104	CcSEcCtD
Vorinostat—Loss of consciousness—Betamethasone—psoriasis	0.000251	0.00104	CcSEcCtD
Vorinostat—Dizziness—Mycophenolic acid—psoriasis	0.000251	0.00104	CcSEcCtD
Vorinostat—Body temperature increased—Cyclosporine—psoriasis	0.000243	0.00101	CcSEcCtD
Vorinostat—Vomiting—Mycophenolic acid—psoriasis	0.000241	0.001	CcSEcCtD
Vorinostat—Headache—Mycophenolic acid—psoriasis	0.000238	0.000988	CcSEcCtD
Vorinostat—Decreased appetite—Hydrocortisone—psoriasis	0.000237	0.000986	CcSEcCtD
Vorinostat—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000237	0.000984	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000236	0.000979	CcSEcCtD
Vorinostat—Fatigue—Hydrocortisone—psoriasis	0.000235	0.000977	CcSEcCtD
Vorinostat—Infection—Dexamethasone—psoriasis	0.000232	0.000962	CcSEcCtD
Vorinostat—Infection—Betamethasone—psoriasis	0.000232	0.000962	CcSEcCtD
Vorinostat—Anaemia—Prednisone—psoriasis	0.00023	0.000955	CcSEcCtD
Vorinostat—Shock—Betamethasone—psoriasis	0.000229	0.000953	CcSEcCtD
Vorinostat—Shock—Dexamethasone—psoriasis	0.000229	0.000953	CcSEcCtD
Vorinostat—Thrombocytopenia—Dexamethasone—psoriasis	0.000228	0.000948	CcSEcCtD
Vorinostat—Thrombocytopenia—Betamethasone—psoriasis	0.000228	0.000948	CcSEcCtD
Vorinostat—Angioedema—Prednisone—psoriasis	0.000227	0.000944	CcSEcCtD
Vorinostat—Nausea—Mycophenolic acid—psoriasis	0.000226	0.000937	CcSEcCtD
Vorinostat—Syncope—Prednisone—psoriasis	0.000223	0.000927	CcSEcCtD
Vorinostat—Anorexia—Dexamethasone—psoriasis	0.000222	0.000923	CcSEcCtD
Vorinostat—Anorexia—Betamethasone—psoriasis	0.000222	0.000923	CcSEcCtD
Vorinostat—Fatigue—Triamcinolone—psoriasis	0.000222	0.00092	CcSEcCtD
Vorinostat—Asthenia—Cyclosporine—psoriasis	0.00022	0.000915	CcSEcCtD
Vorinostat—Loss of consciousness—Prednisone—psoriasis	0.000219	0.000908	CcSEcCtD
Vorinostat—Pruritus—Cyclosporine—psoriasis	0.000217	0.000903	CcSEcCtD
Vorinostat—Body temperature increased—Hydrocortisone—psoriasis	0.000216	0.000896	CcSEcCtD
Vorinostat—Asthenia—Mycophenolate mofetil—psoriasis	0.000215	0.000893	CcSEcCtD
Vorinostat—Chills—Methotrexate—psoriasis	0.000214	0.00089	CcSEcCtD
Vorinostat—Pruritus—Mycophenolate mofetil—psoriasis	0.000212	0.00088	CcSEcCtD
Vorinostat—Alopecia—Methotrexate—psoriasis	0.000211	0.000877	CcSEcCtD
Vorinostat—Diarrhoea—Cyclosporine—psoriasis	0.00021	0.000873	CcSEcCtD
Vorinostat—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000205	0.000851	CcSEcCtD
Vorinostat—Dysgeusia—Methotrexate—psoriasis	0.000204	0.000846	CcSEcCtD
Vorinostat—Body temperature increased—Triamcinolone—psoriasis	0.000203	0.000844	CcSEcCtD
Vorinostat—Dizziness—Cyclosporine—psoriasis	0.000203	0.000844	CcSEcCtD
Vorinostat—Decreased appetite—Betamethasone—psoriasis	0.000203	0.000842	CcSEcCtD
Vorinostat—Decreased appetite—Dexamethasone—psoriasis	0.000203	0.000842	CcSEcCtD
Vorinostat—Infection—Prednisone—psoriasis	0.000202	0.000838	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Betamethasone—psoriasis	0.000201	0.000836	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000201	0.000836	CcSEcCtD
Vorinostat—Fatigue—Dexamethasone—psoriasis	0.000201	0.000835	CcSEcCtD
Vorinostat—Fatigue—Betamethasone—psoriasis	0.000201	0.000835	CcSEcCtD
Vorinostat—Shock—Prednisone—psoriasis	0.0002	0.00083	CcSEcCtD
Vorinostat—Dizziness—Mycophenolate mofetil—psoriasis	0.000198	0.000823	CcSEcCtD
Vorinostat—Asthenia—Hydrocortisone—psoriasis	0.000196	0.000813	CcSEcCtD
Vorinostat—Vomiting—Cyclosporine—psoriasis	0.000195	0.000811	CcSEcCtD
Vorinostat—Anorexia—Prednisone—psoriasis	0.000194	0.000804	CcSEcCtD
Vorinostat—Pruritus—Hydrocortisone—psoriasis	0.000193	0.000802	CcSEcCtD
Vorinostat—Headache—Cyclosporine—psoriasis	0.000192	0.000799	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—psoriasis	0.000192	0.000798	CcSEcCtD
Vorinostat—Vomiting—Mycophenolate mofetil—psoriasis	0.000191	0.000791	CcSEcCtD
Vorinostat—Headache—Mycophenolate mofetil—psoriasis	0.000188	0.00078	CcSEcCtD
Vorinostat—Diarrhoea—Hydrocortisone—psoriasis	0.000187	0.000776	CcSEcCtD
Vorinostat—Leukopenia—Methotrexate—psoriasis	0.000186	0.000773	CcSEcCtD
Vorinostat—Dizziness—Prednisolone—psoriasis	0.000185	0.000768	CcSEcCtD
Vorinostat—Asthenia—Triamcinolone—psoriasis	0.000184	0.000766	CcSEcCtD
Vorinostat—Body temperature increased—Betamethasone—psoriasis	0.000184	0.000766	CcSEcCtD
Vorinostat—Body temperature increased—Dexamethasone—psoriasis	0.000184	0.000766	CcSEcCtD
Vorinostat—Nausea—Cyclosporine—psoriasis	0.000182	0.000758	CcSEcCtD
Vorinostat—Pruritus—Triamcinolone—psoriasis	0.000182	0.000755	CcSEcCtD
Vorinostat—Cough—Methotrexate—psoriasis	0.000182	0.000754	CcSEcCtD
Vorinostat—Dizziness—Hydrocortisone—psoriasis	0.000181	0.00075	CcSEcCtD
Vorinostat—Nausea—Mycophenolate mofetil—psoriasis	0.000178	0.000739	CcSEcCtD
Vorinostat—Chest pain—Methotrexate—psoriasis	0.000177	0.000735	CcSEcCtD
Vorinostat—Decreased appetite—Prednisone—psoriasis	0.000177	0.000733	CcSEcCtD
Vorinostat—Fatigue—Prednisone—psoriasis	0.000175	0.000727	CcSEcCtD
Vorinostat—Headache—Prednisolone—psoriasis	0.000175	0.000727	CcSEcCtD
Vorinostat—Constipation—Prednisone—psoriasis	0.000174	0.000721	CcSEcCtD
Vorinostat—Vomiting—Hydrocortisone—psoriasis	0.000174	0.000721	CcSEcCtD
Vorinostat—Headache—Hydrocortisone—psoriasis	0.000171	0.00071	CcSEcCtD
Vorinostat—Dizziness—Triamcinolone—psoriasis	0.00017	0.000706	CcSEcCtD
Vorinostat—Infection—Methotrexate—psoriasis	0.000169	0.0007	CcSEcCtD
Vorinostat—Asthenia—Dexamethasone—psoriasis	0.000167	0.000695	CcSEcCtD
Vorinostat—Asthenia—Betamethasone—psoriasis	0.000167	0.000695	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—psoriasis	0.000166	0.00069	CcSEcCtD
Vorinostat—Nausea—Prednisolone—psoriasis	0.000166	0.00069	CcSEcCtD
Vorinostat—Pruritus—Dexamethasone—psoriasis	0.000165	0.000685	CcSEcCtD
Vorinostat—Pruritus—Betamethasone—psoriasis	0.000165	0.000685	CcSEcCtD
Vorinostat—Vomiting—Triamcinolone—psoriasis	0.000163	0.000679	CcSEcCtD
Vorinostat—Nausea—Hydrocortisone—psoriasis	0.000162	0.000673	CcSEcCtD
Vorinostat—Anorexia—Methotrexate—psoriasis	0.000162	0.000672	CcSEcCtD
Vorinostat—Headache—Triamcinolone—psoriasis	0.000161	0.000669	CcSEcCtD
Vorinostat—Body temperature increased—Prednisone—psoriasis	0.000161	0.000667	CcSEcCtD
Vorinostat—Diarrhoea—Dexamethasone—psoriasis	0.00016	0.000663	CcSEcCtD
Vorinostat—Diarrhoea—Betamethasone—psoriasis	0.00016	0.000663	CcSEcCtD
Vorinostat—Dizziness—Dexamethasone—psoriasis	0.000154	0.000641	CcSEcCtD
Vorinostat—Dizziness—Betamethasone—psoriasis	0.000154	0.000641	CcSEcCtD
Vorinostat—Nausea—Triamcinolone—psoriasis	0.000153	0.000634	CcSEcCtD
Vorinostat—Vomiting—Betamethasone—psoriasis	0.000148	0.000616	CcSEcCtD
Vorinostat—Vomiting—Dexamethasone—psoriasis	0.000148	0.000616	CcSEcCtD
Vorinostat—Decreased appetite—Methotrexate—psoriasis	0.000148	0.000613	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Methotrexate—psoriasis	0.000147	0.000609	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—psoriasis	0.000146	0.000608	CcSEcCtD
Vorinostat—Headache—Dexamethasone—psoriasis	0.000146	0.000607	CcSEcCtD
Vorinostat—Headache—Betamethasone—psoriasis	0.000146	0.000607	CcSEcCtD
Vorinostat—Asthenia—Prednisone—psoriasis	0.000146	0.000605	CcSEcCtD
Vorinostat—Pruritus—Prednisone—psoriasis	0.000144	0.000597	CcSEcCtD
Vorinostat—Diarrhoea—Prednisone—psoriasis	0.000139	0.000577	CcSEcCtD
Vorinostat—Nausea—Betamethasone—psoriasis	0.000139	0.000575	CcSEcCtD
Vorinostat—Nausea—Dexamethasone—psoriasis	0.000139	0.000575	CcSEcCtD
Vorinostat—HDAC1—Factors involved in megakaryocyte development and platelet production—TP53—psoriasis	0.000138	0.000519	CbGpPWpGaD
Vorinostat—NCOR1—Generic Transcription Pathway—PPARG—psoriasis	0.000137	0.000515	CbGpPWpGaD
Vorinostat—HDAC3—Circadian rythm related genes—TP53—psoriasis	0.000135	0.000507	CbGpPWpGaD
Vorinostat—Dizziness—Prednisone—psoriasis	0.000134	0.000558	CcSEcCtD
Vorinostat—Body temperature increased—Methotrexate—psoriasis	0.000134	0.000557	CcSEcCtD
Vorinostat—HDAC3—Metabolism—CARM1—psoriasis	0.000134	0.000504	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—TP53—psoriasis	0.000133	0.000501	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—STAT3—psoriasis	0.000133	0.000501	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000132	0.000497	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCL20—psoriasis	0.000132	0.000495	CbGpPWpGaD
Vorinostat—HDAC2—Direct p53 effectors—JUN—psoriasis	0.000132	0.000495	CbGpPWpGaD
Vorinostat—HDAC11—Disease—APOE—psoriasis	0.00013	0.000489	CbGpPWpGaD
Vorinostat—Vomiting—Prednisone—psoriasis	0.000129	0.000536	CcSEcCtD
Vorinostat—HDAC1—Gene Expression—CARM1—psoriasis	0.000129	0.000485	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—PPARG—psoriasis	0.000129	0.000484	CbGpPWpGaD
Vorinostat—Headache—Prednisone—psoriasis	0.000127	0.000528	CcSEcCtD
Vorinostat—HDAC1—Integrated Breast Cancer Pathway—TP53—psoriasis	0.000127	0.000477	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000125	0.000471	CbGpPWpGaD
Vorinostat—NCOR1—Circadian rythm related genes—TP53—psoriasis	0.000124	0.000466	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—PCNA—psoriasis	0.000124	0.000466	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—SOCS1—psoriasis	0.000123	0.000464	CbGpPWpGaD
Vorinostat—HDAC3—Circadian rythm related genes—IL6—psoriasis	0.000123	0.000464	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—CARM1—psoriasis	0.000123	0.000463	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—TYK2—psoriasis	0.000123	0.000462	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HCAR2—psoriasis	0.000122	0.00046	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.000122	0.000459	CbGpPWpGaD
Vorinostat—Asthenia—Methotrexate—psoriasis	0.000122	0.000506	CcSEcCtD
Vorinostat—HDAC11—Disease—NOS2—psoriasis	0.000121	0.000456	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCL20—psoriasis	0.000121	0.000455	CbGpPWpGaD
Vorinostat—Nausea—Prednisone—psoriasis	0.000121	0.000501	CcSEcCtD
Vorinostat—Pruritus—Methotrexate—psoriasis	0.00012	0.000499	CcSEcCtD
Vorinostat—HDAC6—Disease—HLA-A—psoriasis	0.000117	0.000439	CbGpPWpGaD
Vorinostat—Diarrhoea—Methotrexate—psoriasis	0.000116	0.000482	CcSEcCtD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000115	0.000433	CbGpPWpGaD
Vorinostat—NCOR1—Circadian rythm related genes—IL6—psoriasis	0.000113	0.000426	CbGpPWpGaD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—IL6—psoriasis	0.000113	0.000426	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—TYK2—psoriasis	0.000113	0.000424	CbGpPWpGaD
Vorinostat—Dizziness—Methotrexate—psoriasis	0.000112	0.000466	CcSEcCtD
Vorinostat—HDAC2—Signaling by NGF—NFKBIA—psoriasis	0.000112	0.000422	CbGpPWpGaD
Vorinostat—HDAC2—Cell Cycle—TP53—psoriasis	0.000112	0.000421	CbGpPWpGaD
Vorinostat—HDAC1—Generic Transcription Pathway—PPARG—psoriasis	0.000112	0.00042	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—VDR—psoriasis	0.000111	0.000418	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—NFKB1—psoriasis	0.000111	0.000417	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—NOS2—psoriasis	0.00011	0.000414	CbGpPWpGaD
Vorinostat—HDAC6—Disease—APOE—psoriasis	0.000109	0.00041	CbGpPWpGaD
Vorinostat—Vomiting—Methotrexate—psoriasis	0.000108	0.000448	CcSEcCtD
Vorinostat—Headache—Methotrexate—psoriasis	0.000106	0.000442	CcSEcCtD
Vorinostat—HDAC2—Signaling by NOTCH—TP53—psoriasis	0.000106	0.000399	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TAGAP—psoriasis	0.000106	0.000399	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HLA-A—psoriasis	0.000106	0.000397	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—SOCS1—psoriasis	0.000103	0.000389	CbGpPWpGaD
Vorinostat—HDAC6—Disease—NOS2—psoriasis	0.000102	0.000382	CbGpPWpGaD
Vorinostat—HDAC1—Circadian rythm related genes—TP53—psoriasis	0.000101	0.00038	CbGpPWpGaD
Vorinostat—Nausea—Methotrexate—psoriasis	0.000101	0.000419	CcSEcCtD
Vorinostat—HDAC1—Signaling by NGF—STAT3—psoriasis	9.98e-05	0.000375	CbGpPWpGaD
Vorinostat—HDAC11—Disease—TYK2—psoriasis	9.93e-05	0.000373	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCL20—psoriasis	9.87e-05	0.000371	CbGpPWpGaD
Vorinostat—HDAC4—Disease—APOE—psoriasis	9.86e-05	0.000371	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—JUN—psoriasis	9.86e-05	0.000371	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HLA-A—psoriasis	9.75e-05	0.000366	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—NFKB1—psoriasis	9.58e-05	0.00036	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—VDR—psoriasis	9.46e-05	0.000355	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—SOCS1—psoriasis	9.36e-05	0.000352	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—IL6—psoriasis	9.31e-05	0.00035	CbGpPWpGaD
Vorinostat—HDAC1—Circadian rythm related genes—IL6—psoriasis	9.25e-05	0.000347	CbGpPWpGaD
Vorinostat—HDAC4—Disease—NOS2—psoriasis	9.19e-05	0.000345	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—TYK2—psoriasis	9.19e-05	0.000345	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HLA-A—psoriasis	9.12e-05	0.000343	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—APOE—psoriasis	9.11e-05	0.000343	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—LEP—psoriasis	9.11e-05	0.000343	CbGpPWpGaD
Vorinostat—HDAC8—Disease—APOE—psoriasis	9.1e-05	0.000342	CbGpPWpGaD
Vorinostat—HDAC11—Disease—CD4—psoriasis	8.98e-05	0.000338	CbGpPWpGaD
Vorinostat—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—psoriasis	8.9e-05	0.000334	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—NFKB1—psoriasis	8.8e-05	0.000331	CbGpPWpGaD
Vorinostat—HDAC2—Direct p53 effectors—TP53—psoriasis	8.69e-05	0.000327	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—VEGFA—psoriasis	8.69e-05	0.000327	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SOCS1—psoriasis	8.64e-05	0.000325	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—STAT3—psoriasis	8.61e-05	0.000323	CbGpPWpGaD
Vorinostat—HDAC9—Disease—APOE—psoriasis	8.51e-05	0.00032	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—NFKBIA—psoriasis	8.49e-05	0.000319	CbGpPWpGaD
Vorinostat—HDAC8—Disease—NOS2—psoriasis	8.48e-05	0.000319	CbGpPWpGaD
Vorinostat—HDAC6—Disease—TYK2—psoriasis	8.32e-05	0.000313	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—CARM1—psoriasis	8.32e-05	0.000313	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—CAT—psoriasis	8.24e-05	0.00031	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HLA-A—psoriasis	8.19e-05	0.000308	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SOCS1—psoriasis	8.08e-05	0.000304	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—VEGFA—psoriasis	7.99e-05	0.0003	CbGpPWpGaD
Vorinostat—HDAC9—Disease—NOS2—psoriasis	7.93e-05	0.000298	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—STAT3—psoriasis	7.91e-05	0.000297	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—PPARG—psoriasis	7.75e-05	0.000291	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—VDR—psoriasis	7.71e-05	0.00029	CbGpPWpGaD
Vorinostat—HDAC3—Disease—APOE—psoriasis	7.65e-05	0.000287	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—LEP—psoriasis	7.64e-05	0.000287	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—APOE—psoriasis	7.64e-05	0.000287	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—CAT—psoriasis	7.57e-05	0.000285	CbGpPWpGaD
Vorinostat—HDAC4—Disease—TYK2—psoriasis	7.53e-05	0.000283	CbGpPWpGaD
Vorinostat—HDAC6—Disease—CD4—psoriasis	7.53e-05	0.000283	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HLA-A—psoriasis	7.53e-05	0.000283	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—TNF—psoriasis	7.45e-05	0.00028	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SOCS1—psoriasis	7.26e-05	0.000273	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—TP53—psoriasis	7.24e-05	0.000272	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—NFKB1—psoriasis	7.16e-05	0.000269	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NOS2—psoriasis	7.13e-05	0.000268	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NFKBIA—psoriasis	7.12e-05	0.000267	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NOS2—psoriasis	7.11e-05	0.000267	CbGpPWpGaD
Vorinostat—NCOR1—Disease—APOE—psoriasis	7.03e-05	0.000264	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—IL6—psoriasis	6.97e-05	0.000262	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TYK2—psoriasis	6.96e-05	0.000261	CbGpPWpGaD
Vorinostat—HDAC11—Disease—STAT3—psoriasis	6.96e-05	0.000261	CbGpPWpGaD
Vorinostat—HDAC8—Disease—TYK2—psoriasis	6.95e-05	0.000261	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—LEP—psoriasis	6.91e-05	0.00026	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—APOE—psoriasis	6.91e-05	0.00026	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—TNF—psoriasis	6.84e-05	0.000257	CbGpPWpGaD
Vorinostat—HDAC4—Disease—CD4—psoriasis	6.81e-05	0.000256	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SOCS1—psoriasis	6.67e-05	0.000251	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—PPARG—psoriasis	6.59e-05	0.000248	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NOS2—psoriasis	6.55e-05	0.000246	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—TP53—psoriasis	6.51e-05	0.000245	CbGpPWpGaD
Vorinostat—HDAC9—Disease—TYK2—psoriasis	6.5e-05	0.000244	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NFKBIA—psoriasis	6.44e-05	0.000242	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—STAT3—psoriasis	6.43e-05	0.000242	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—APOE—psoriasis	6.4e-05	0.000241	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—VEGFA—psoriasis	6.39e-05	0.00024	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—LEP—psoriasis	6.37e-05	0.00024	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—APOE—psoriasis	6.37e-05	0.00024	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCL20—psoriasis	6.36e-05	0.000239	CbGpPWpGaD
Vorinostat—HDAC8—Disease—CD4—psoriasis	6.28e-05	0.000236	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HLA-A—psoriasis	6.14e-05	0.000231	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CXCL8—psoriasis	6.06e-05	0.000228	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—IL6—psoriasis	6.01e-05	0.000226	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—APOE—psoriasis	5.96e-05	0.000224	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—LEP—psoriasis	5.96e-05	0.000224	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—IL6—psoriasis	5.96e-05	0.000224	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NFKBIA—psoriasis	5.94e-05	0.000223	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—APOE—psoriasis	5.89e-05	0.000221	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CD4—psoriasis	5.88e-05	0.000221	CbGpPWpGaD
Vorinostat—HDAC3—Disease—TYK2—psoriasis	5.84e-05	0.000219	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TYK2—psoriasis	5.83e-05	0.000219	CbGpPWpGaD
Vorinostat—HDAC6—Disease—STAT3—psoriasis	5.83e-05	0.000219	CbGpPWpGaD
Vorinostat—HDAC1—Disease—APOE—psoriasis	5.73e-05	0.000215	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—JUN—psoriasis	5.63e-05	0.000212	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PPARG—psoriasis	5.58e-05	0.00021	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NFKBIA—psoriasis	5.56e-05	0.000209	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—IL6—psoriasis	5.52e-05	0.000208	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SOCS1—psoriasis	5.44e-05	0.000204	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—NFKB1—psoriasis	5.42e-05	0.000204	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—PPARG—psoriasis	5.37e-05	0.000202	CbGpPWpGaD
Vorinostat—NCOR1—Disease—TYK2—psoriasis	5.36e-05	0.000202	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—LEP—psoriasis	5.36e-05	0.000201	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—APOE—psoriasis	5.36e-05	0.000201	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NOS2—psoriasis	5.34e-05	0.000201	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CD4—psoriasis	5.28e-05	0.000198	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TYK2—psoriasis	5.27e-05	0.000198	CbGpPWpGaD
Vorinostat—HDAC4—Disease—STAT3—psoriasis	5.27e-05	0.000198	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PPARG—psoriasis	5.13e-05	0.000193	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CXCL8—psoriasis	5.08e-05	0.000191	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NFKBIA—psoriasis	4.99e-05	0.000188	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—VDR—psoriasis	4.97e-05	0.000187	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—APOE—psoriasis	4.92e-05	0.000185	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—LEP—psoriasis	4.92e-05	0.000185	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—VEGFA—psoriasis	4.92e-05	0.000185	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—STAT3—psoriasis	4.87e-05	0.000183	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TYK2—psoriasis	4.86e-05	0.000183	CbGpPWpGaD
Vorinostat—HDAC8—Disease—STAT3—psoriasis	4.86e-05	0.000183	CbGpPWpGaD
Vorinostat—HDAC11—Disease—IL6—psoriasis	4.86e-05	0.000183	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CD4—psoriasis	4.85e-05	0.000182	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—psoriasis	4.83e-05	0.000181	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—JUN—psoriasis	4.72e-05	0.000177	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CXCL8—psoriasis	4.59e-05	0.000173	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NFKBIA—psoriasis	4.59e-05	0.000172	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—psoriasis	4.55e-05	0.000171	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TYK2—psoriasis	4.55e-05	0.000171	CbGpPWpGaD
Vorinostat—HDAC9—Disease—STAT3—psoriasis	4.55e-05	0.000171	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NFKB1—psoriasis	4.54e-05	0.000171	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—IL6—psoriasis	4.49e-05	0.000169	CbGpPWpGaD
Vorinostat—HDAC1—Disease—TYK2—psoriasis	4.37e-05	0.000164	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—JUN—psoriasis	4.27e-05	0.00016	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CXCL8—psoriasis	4.24e-05	0.000159	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—VEGFA—psoriasis	4.12e-05	0.000155	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—psoriasis	4.12e-05	0.000155	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NFKB1—psoriasis	4.11e-05	0.000154	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TYK2—psoriasis	4.09e-05	0.000154	CbGpPWpGaD
Vorinostat—HDAC3—Disease—STAT3—psoriasis	4.09e-05	0.000154	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—STAT3—psoriasis	4.08e-05	0.000153	CbGpPWpGaD
Vorinostat—HDAC6—Disease—IL6—psoriasis	4.07e-05	0.000153	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APOE—psoriasis	4.01e-05	0.000151	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—LEP—psoriasis	4.01e-05	0.000151	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CXCL8—psoriasis	3.96e-05	0.000149	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CD4—psoriasis	3.95e-05	0.000149	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HLA-A—psoriasis	3.95e-05	0.000149	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—JUN—psoriasis	3.94e-05	0.000148	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NFKB1—psoriasis	3.79e-05	0.000142	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TYK2—psoriasis	3.76e-05	0.000141	CbGpPWpGaD
Vorinostat—NCOR1—Disease—STAT3—psoriasis	3.76e-05	0.000141	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NFKBIA—psoriasis	3.74e-05	0.000141	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—psoriasis	3.73e-05	0.00014	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—psoriasis	3.72e-05	0.00014	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APOE—psoriasis	3.69e-05	0.000139	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—STAT3—psoriasis	3.69e-05	0.000139	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—JUN—psoriasis	3.68e-05	0.000138	CbGpPWpGaD
Vorinostat—HDAC4—Disease—IL6—psoriasis	3.68e-05	0.000138	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CXCL8—psoriasis	3.56e-05	0.000134	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NFKB1—psoriasis	3.55e-05	0.000133	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SOCS1—psoriasis	3.5e-05	0.000132	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—PPARG—psoriasis	3.46e-05	0.00013	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—psoriasis	3.44e-05	0.000129	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS2—psoriasis	3.44e-05	0.000129	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—STAT3—psoriasis	3.41e-05	0.000128	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL6—psoriasis	3.4e-05	0.000128	CbGpPWpGaD
Vorinostat—HDAC8—Disease—IL6—psoriasis	3.4e-05	0.000128	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—JUN—psoriasis	3.31e-05	0.000124	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CXCL8—psoriasis	3.27e-05	0.000123	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—psoriasis	3.22e-05	0.000121	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—STAT3—psoriasis	3.19e-05	0.00012	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NFKB1—psoriasis	3.18e-05	0.00012	CbGpPWpGaD
Vorinostat—HDAC9—Disease—IL6—psoriasis	3.18e-05	0.000119	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—psoriasis	3.11e-05	0.000117	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—psoriasis	3.11e-05	0.000117	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TYK2—psoriasis	3.06e-05	0.000115	CbGpPWpGaD
Vorinostat—HDAC1—Disease—STAT3—psoriasis	3.06e-05	0.000115	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—JUN—psoriasis	3.04e-05	0.000114	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NFKB1—psoriasis	2.93e-05	0.00011	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—psoriasis	2.89e-05	0.000109	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—STAT3—psoriasis	2.86e-05	0.000108	CbGpPWpGaD
Vorinostat—HDAC3—Disease—IL6—psoriasis	2.85e-05	0.000107	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL6—psoriasis	2.85e-05	0.000107	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TYK2—psoriasis	2.82e-05	0.000106	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—psoriasis	2.82e-05	0.000106	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CXCL8—psoriasis	2.67e-05	0.0001	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—psoriasis	2.66e-05	9.98e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—STAT3—psoriasis	2.63e-05	9.88e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—IL6—psoriasis	2.62e-05	9.86e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—psoriasis	2.6e-05	9.77e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—LEP—psoriasis	2.59e-05	9.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APOE—psoriasis	2.59e-05	9.72e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL6—psoriasis	2.58e-05	9.69e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CD4—psoriasis	2.55e-05	9.58e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—JUN—psoriasis	2.48e-05	9.32e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—psoriasis	2.43e-05	9.14e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NFKBIA—psoriasis	2.41e-05	9.05e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NFKB1—psoriasis	2.39e-05	8.97e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL6—psoriasis	2.38e-05	8.94e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL6—psoriasis	2.23e-05	8.36e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—psoriasis	2.18e-05	8.21e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—psoriasis	2.17e-05	8.14e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—STAT3—psoriasis	2.14e-05	8.06e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—IL6—psoriasis	2.14e-05	8.04e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—psoriasis	2.01e-05	7.54e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL6—psoriasis	2e-05	7.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TYK2—psoriasis	1.97e-05	7.42e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—STAT3—psoriasis	1.97e-05	7.42e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL6—psoriasis	1.84e-05	6.9e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCL8—psoriasis	1.72e-05	6.46e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—psoriasis	1.64e-05	6.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—JUN—psoriasis	1.6e-05	6e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NFKB1—psoriasis	1.54e-05	5.78e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6—psoriasis	1.5e-05	5.63e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—psoriasis	1.4e-05	5.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STAT3—psoriasis	1.38e-05	5.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6—psoriasis	1.38e-05	5.18e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—psoriasis	1.05e-05	3.96e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6—psoriasis	9.65e-06	3.63e-05	CbGpPWpGaD
